20n Bio Revenue

Biotechnology Research • Philadelphia, Pennsylvania, United States • 1-10 Employees

20n Bio revenue & valuation

Annual revenue	$230,000
Revenue per employee	$46,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$736,000
Total funding	$3,300,000

Key Contact at 20n Bio

Mingfu Zhu

Founder and CEO

Company overview

Headquarters	Philadelphia, Pennsylvania, United States
Website	20n.bio
NAICS	541714
Founded	2021
Employees	1-10
Socials

20n Bio Email Formats

20n Bio uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@20n.bio), used 100% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@20n.bio	100%

About 20n Bio

20n Bio is a VC-backed start-up dedicated to designing and screening cyclic peptides for therapeutics. Launched in 2021 and located in Malvern PA, its mission is addressing unmet medical needs by leveraging high-throughput screening and computing to generate peptide drugs with desired biophysical, functional, and pharmacological properties.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

20n Bio has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore 20n Bio's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-01-17	3	$3,300,000

Funding Insights

$3,300,000

Total funding amount

$3,300,000

Most recent funding amount

Number of funding rounds

20n Bio Tech Stack

Discover the technologies and tools that power 20n Bio's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

reCAPTCHA

Security

Open Graph

Miscellaneous

lit-element

JavaScript libraries

Google Maps

Maps

Google Sites

CMS

lit-html

JavaScript libraries

Google Font API

Font scripts

Frequently asked questions

20n Bio is located in Philadelphia, Pennsylvania, US.

20n Bio generates an estimated annual revenue of $230,000. This revenue figure reflects the company's market position and business performance in its industry.

20n Bio has an estimated valuation of $736,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

20n Bio was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

20n Bio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

20n Bio has raised a total of $3,300,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at 20n Bio

Mingfu Zhu

Founder and CEO

4.8

40,000 users